Magnite (MGNI) Rule 144 Notice — 12,403 Shares Listed for Sale
Rhea-AI Filing Summary
Magnite, Inc. (MGNI) Form 144 summary: This notice reports a proposed sale under Rule 144 of 12,403 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $323,399.54. The shares were originally acquired as restricted stock on 02/14/2021 from the issuer and were fully paid on that date. The filer (identified in prior transactions as Aaron Saltz) has disclosed multiple recent open-market sales during June–August 2025 totaling 69,325 shares with gross proceeds shown for each trade. The filing includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.
Positive
- Complies with Rule 144 disclosure requirements by providing acquisition details, broker, and recent sales
- Multiple prior sales disclosed, improving transparency about insider transactions
Negative
- Insider selling activity continues (69,325 shares sold in June–August 2025), which could be viewed negatively by some investors
- Form shows ongoing monetization of restricted shares by an insider, potentially increasing share supply
Insights
TL;DR: Routine insider resale of restricted shares under Rule 144; disclosed recent sales show ongoing liquidation activity but small relative to shares outstanding.
The filing documents a compliant Rule 144 notice for 12,403 shares valued at $323,399.54, acquired as restricted stock in 2021. Recent disclosed sales (totaling 69,325 shares across June–August 2025) indicate the insider has been regularly monetizing holdings. With 142,399,305 shares outstanding, the single proposed sale is de minimis relative to the float. The filing does not disclose any material nonpublic information and includes the required seller attestation.
TL;DR: Filing is procedural and compliant; disclosure of past sales enhances transparency but does not signal governance issues on its face.
The notice follows Rule 144 format, identifying acquisition type, payment date, and broker. Multiple past sales by the same person are listed with dates and proceeds, which provides visibility into insider transactions. There are no statements in the form indicating undisclosed adverse information. From a governance perspective, the document meets disclosure norms for officer/director sales.